Validation of COMPAT-SF Spanish Translation
Recruiting
- Conditions
- Chronic Pancreatitis
- Registration Number
- NCT06698302
- Lead Sponsor
- Methodist Health System
- Brief Summary
Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.
- Detailed Description
Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- 18 years or older in age
- Have a definite CP diagnosis and a stable pain pattern with no new interventions or medications in the last three months
- Able to read and understand the study information in Spanish
- Personally signed and dated ICF indicating that the subject has been informed of all pertinent aspects of the study
- Subject is willing and able to comply with the scheduled questionnaires
Exclusion Criteria
- Subjects who do not meet the criteria in section 4.1
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Face validity: through study completion, up to 18 months Patient-reported feedback through a questionnaire concerning the feasibility of the translated COMPAT-SF questionnaire
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Methodist Dallas Medical Center- Clinical Research Institute
🇺🇸Dallas, Texas, United States